Cargando…
CRISPR/Cas9 and next generation sequencing in the personalized treatment of Cancer
BACKGROUND: Cancer is caused by a combination of genetic and epigenetic abnormalities. Current cancer therapies are limited due to the complexity of their mechanism, underlining the need for alternative therapeutic approaches. Interestingly, combining the Clustered Regularly Interspaced Short Palind...
Autores principales: | Selvakumar, Sushmaa Chandralekha, Preethi, K. Auxzilia, Ross, Kehinde, Tusubira, Deusdedit, Khan, Mohd Wajid Ali, Mani, Panagal, Rao, Tentu Nageswara, Sekar, Durairaj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944095/ https://www.ncbi.nlm.nih.gov/pubmed/35331236 http://dx.doi.org/10.1186/s12943-022-01565-1 |
Ejemplares similares
-
MicroRNAs in the epigenetic regulation of disease progression in Parkinson’s disease
por: Selvakumar, Sushmaa Chandralekha, et al.
Publicado: (2022) -
Liquid biopsy: Exosomal microRNAs as novel diagnostic and prognostic biomarkers in cancer
por: Preethi, K. Auxzilia, et al.
Publicado: (2022) -
Relevance of micro-RNAs and their targets as a diagnostic and prognostic marker in oral squamous cell carcinoma
por: Thomas, Priya, et al.
Publicado: (2023) -
Corrigendum: TDP-43 and NEAT long non-coding RNA: Roles in neurodegenerative disease
por: Sekar, Durairaj, et al.
Publicado: (2022) -
TDP-43 and NEAT long non-coding RNA: Roles in neurodegenerative disease
por: Sekar, Durairaj, et al.
Publicado: (2022)